A-68930 hydrochloride
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 533327

CAS#: 130465-39-3

Description: A-68930 hydrochloride is a selective D1 dopamine receptor agonist, ameliorates Aβ1-42-induced cognitive impairment and neuroinflammation in mice, showing promise in treating Alzheimer's disease. Additionally, A-68930 (10-50 microg/ml) inhibits the gastric H(+) K(+)-ATPase activity comparably to omeprazole.


Chemical Structure

img
A-68930 hydrochloride
CAS# 130465-39-3

Theoretical Analysis

MedKoo Cat#: 533327
Name: A-68930 hydrochloride
CAS#: 130465-39-3
Chemical Formula: C16H18ClNO3
Exact Mass: 307.10
Molecular Weight: 307.774
Elemental Analysis: C, 62.44; H, 5.90; Cl, 11.52; N, 4.55; O, 15.59

Price and Availability

Size Price Availability Quantity
10mg USD 350 2 Weeks
50mg USD 1150 2 Weeks
Bulk inquiry

Synonym: A-68930 hydrochloride; A 68930 hydrochloride; A68930 hydrochloride

IUPAC/Chemical Name: cis-1-(Aminomethyl)-3-phenylisochroman-5,6-diol hydrochloride

InChi Key: PQPGUUQPTSMLKU-CTHHTMFSSA-N

InChi Code: InChI=1S/C16H17NO3.ClH/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10;/h1-7,14-15,18-19H,8-9,17H2;1H/t14-,15-;/m1./s1

SMILES Code: OC1=C(O)C=CC2=C1C[C@H](C3=CC=CC=C3)O[C@@H]2CN.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 307.77 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Martin YC. The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413. Int J Med Chem. 2011;2011:424535. doi: 10.1155/2011/424535. Epub 2011 Mar 24. PMID: 25954518; PMCID: PMC4412209.


2: Cheng ZY, Xia QP, Hu YH, Wang C, He L. Dopamine D1 receptor agonist A-68930 ameliorates Aβ1-42-induced cognitive impairment and neuroinflammation in mice. Int Immunopharmacol. 2020 Nov;88:106963. doi: 10.1016/j.intimp.2020.106963. Epub 2020 Sep 10. PMID: 33182028.


3: Cheng ZY, Hu YH, Xia QP, Wang C, He L. DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model. Brain Res Bull. 2021 Oct;175:136-149. doi: 10.1016/j.brainresbull.2021.07.015. Epub 2021 Jul 17. PMID: 34284074.


4: AI-Naser HA, Cooper SJ. A-68930, a novel, potent dopamine D1 receptor agonist: a microstructural analysis of its effects on feeding and other behaviour in the rat. Behav Pharmacol. 1994 Apr;5(2):210-218. PMID: 11224270.


5: Rasheed N, Ahmad A, Singh N, Singh P, Mishra V, Banu N, Lohani M, Sharma S, Palit G. Differential response of A 68930 and sulpiride in stress-induced gastric ulcers in rats. Eur J Pharmacol. 2010 Sep 15;643(1):121-8. doi: 10.1016/j.ejphar.2010.06.032. Epub 2010 Jun 28. PMID: 20599913.


6: Jiang W, Huang Y, He F, Liu J, Li M, Sun T, Ren W, Hou J, Zhu L. Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury. Spine (Phila Pa 1976). 2016 Mar;41(6):E330-4. doi: 10.1097/BRS.0000000000001287. PMID: 26966979.


7: Isacson R, Kull B, Wahlestedt C, Salmi P. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Neuroscience. 2004;124(1):33-42. doi: 10.1016/j.neuroscience.2003.11.016. PMID: 14960337.


8: Jiang W, Li M, He F, Bian Z, Liu J, He Q, Wang X, Sun T, Zhu L. Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury. Spinal Cord. 2016 Nov;54(11):951-956. doi: 10.1038/sc.2016.52. Epub 2016 Apr 12. PMID: 27067657.


9: Nergårdh R, Oerther S, Fredholm BB. Differences between A 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors. Pharmacol Biochem Behav. 2005 Nov;82(3):495-505. doi: 10.1016/j.pbb.2005.09.017. Epub 2005 Nov 28. PMID: 16318870.


10: Christie MI, Smith GW. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam. J Pharmacol Exp Ther. 1994 Feb;268(2):565-70. PMID: 7906731.


11: Salmi P, Ahlenius S. Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior. Neuroreport. 2000 Apr 27;11(6):1269-72. doi: 10.1097/00001756-200004270-00025. PMID: 10817605.


12: Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. J Pharmacol Exp Ther. 1992 Aug;262(2):855-65. PMID: 1354257.


13: Deveney AM, Waddington JL. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213. Psychopharmacology (Berl). 1996 Mar;124(1-2):40-9. doi: 10.1007/BF02245604. PMID: 8935799.


14: Liu J, Jin Y, Wang B, Wang Y, Zuo S, Zhang J. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome. Biochem Biophys Res Commun. 2021 Jul 5;561:7-13. doi: 10.1016/j.bbrc.2021.04.098. Epub 2021 May 13. PMID: 33992835.


15: Rasheed N, Ahmad A, Pandey CP, Chaturvedi RK, Lohani M, Palit G. Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem Res. 2010 Jan;35(1):22-32. doi: 10.1007/s11064-009-0026-5. Epub 2009 Jul 1. PMID: 19568932.


16: Daly SA, Waddington JL. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213. Br J Pharmacol. 1994 Nov;113(3):839-44. doi: 10.1111/j.1476-5381.1994.tb17069.x. PMID: 7858875; PMCID: PMC1510419.


17: Daly SA, Waddington JL. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. Psychopharmacology (Berl). 1993;113(1):45-50. doi: 10.1007/BF02244332. PMID: 7862827.


18: Gronier B, Waters S, Ponten H. The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex. J Neural Transm (Vienna). 2013 Sep;120(9):1281-94. doi: 10.1007/s00702-013-1002-4. Epub 2013 Mar 7. PMID: 23468085.


19: Salmi P. Independent roles of dopamine D1 and D2/3 receptors in rat thermoregulation. Brain Res. 1998 Jan 19;781(1-2):188-93. doi: 10.1016/s0006-8993(97)01229-8. PMID: 9507118.


20: Kurokawa K, Mizuno K, Ohkuma S. Increase of ryanodine receptors by dopamine D1 receptors is negatively regulated by γ-aminobutyric acid type B receptors in primary cultures of mouse cerebral cortical neurons. J Neurosci Res. 2012 Aug;90(8):1626-38. doi: 10.1002/jnr.23058. Epub 2012 Apr 14. PMID: 22504960.